Genworth Financial Inc

Description

Genworth Financial, Inc., together with its subsidiaries, provides mortgage and long-term care insurance products in the United States and internationally. It operates in three segments: Enact, Long-Term Care Insurance, and Life and Annuities. The Enact segment offers private mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products. The Long-Term Care Insurance segment offers long-term care insurance products that are intended to protect against the significant and escalating costs of long-term care services provided in the insured's home, assisted living, and nursing facilities. The Life and Annuities segment provides protection and retirement income products, that includes traditional and non-traditional life insurance, such as term, universal and term universal life insurance, corporate-owned life insurance, and funding agreements; fixed annuities; and variable annuities. It distributes its products through sales force, in-house sales representatives, and digital marketing programs. The company was founded in 1871 and is headquartered in Richmond, Virginia.

About

CEO
Mr. Thomas Joseph McInerney
Employees
2,700
Instrument type
Common Stock
Sector
Financial Services
Industry
Insurance - Life
MIC code
XNYS
Address
6620 West Broad Street, Richmond, VA 23230, United States
Phone
804 281 6000
Website
Chart Image
× Enlarged Chart
Oscillators
Invalid data format
Summary
Invalid data format
Moving Averages
Invalid data format

Earnings

Date Estimate EPS Actual EPS Difference % Surprise
Nov 5, 2025
Jul 29, 2025
Apr 29, 2025
Feb 19, 2025 0.18
Nov 7, 2024 0.19 0.19 0.00 0.00%

Earnings estimate

Next Quarter
(Mar 2025)
Next Year
(Dec 2025)
Number of analysts 0 1
Average estimate 0.00 0.67
Low estimate 0.00 0.67
High estimate 0.00 0.67
Last year EPS 0.19 0.70
[stock_revenue_estimate]

Growth estimates

Current qtr
123.530%
Next qtr. (Mar 2025)
Current year
677.780%
Next year (Dec 2025)
-4.290%
Next 5 years (per annum)
Past 5 years (per annum)

Analyst Ratings

Date Firm Action Rating Price Target
Apr 10, 2024
Keefe, Bruyette & Woods
Ryan Krueger
Maintains Market Perform ▲ Raises $6.5 → $7
Jun 11, 2018
Wells Fargo
Sean Dargan
Maintains Market Perform ▲ Raises $3 → $5
Nov 11, 2016
Compass Point
Upgrade Buy
Oct 5, 2016
BTIG
Downgrade Neutral
Oct 5, 2016
BTIG Research
Downgrade Neutral
Sep 23, 2016
Goldman Sachs
Maintains Neutral ▲ Raises $3 → $4
Sep 19, 2016
Compass Point
Downgrade Neutral
Feb 9, 2016
UBS
Maintains Sell ▼ Lowers $2.25 → $1.75
Jan 22, 2016
UBS
Maintains Sell ▼ Lowers $3.5 → $2.25
Nov 17, 2015
Goldman Sachs
Initiates Neutral
Nov 4, 2015
UBS
Downgrade Sell
Oct 5, 2015
JP Morgan
Maintains Neutral ▼ Lowers $9 → $8
Sep 17, 2015
Macquarie
Maintains Neutral ▲ Raises $5 → $7
Sep 2, 2015
Keefe, Bruyette & Woods
Maintains ▼ Lowers $8 → $6
Sep 2, 2015
Keefe Bruyette & Woods
Maintains
Aug 6, 2015
Raymond James
Downgrade Outperform
Aug 5, 2015
Macquarie
Upgrade Neutral
May 28, 2015
Morgan Stanley
Upgrade Equal-Weight
May 15, 2015
Keefe Bruyette & Woods
Maintains Market Perform
May 15, 2015
Keefe, Bruyette & Woods
Maintains Market Perform ▼ Lowers $9 → $8
May 5, 2015
Morgan Stanley
Downgrade Underweight
Apr 30, 2015
Compass Point
Downgrade Neutral
Apr 22, 2015
Keefe Bruyette & Woods
Maintains Market Perform
Apr 22, 2015
Keefe, Bruyette & Woods
Maintains Market Perform ▼ Lowers $9.5 → $9
Mar 23, 2015
Raymond James
Upgrade Strong Buy
Feb 20, 2015
Keefe, Bruyette & Woods
Maintains Market Perform ▼ Lowers $10 → $9.5
Feb 20, 2015
Keefe Bruyette & Woods
Maintains Market Perform
Feb 11, 2015
JP Morgan
Maintains Neutral ▼ Lowers $11 → $9
Jan 27, 2015
Keefe Bruyette & Woods
Maintains Market Perform
Jan 27, 2015
Keefe, Bruyette & Woods
Maintains Market Perform ▼ Lowers $10.5 → $10

Income statement

2023 2022 2021 2020 2019
Fiscal date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total reported revenue 7.37B 7.40B 7.60B 8.21B 7.71B
Cost of revenue
Gross profit
Operating expense
Research & development
Selling general and admin
Other operating expenses 5.00M
Operating income
Non operating interest income
Income
Expense 621.00M 610.00M 671.00M 744.00M 808.00M
Other income expense
Pretax income 303.00M 1.37B 1.11B 928.00M 521.00M
Tax provision 104.00M 319.00M 248.00M 230.00M 139.00M
Net income 199.00M 1.05B 891.00M 212.00M 530.00M
Basic EPS 0.16 1.21 1.78 0.35 0.68
Diluted EPS 0.16 1.19 1.76 0.35 0.67
Basic average shares 468.80M 504.50M 506.90M 505.20M 502.90M
Diluted average shares 468.80M 504.50M 506.90M 505.20M 502.90M
EBITDA
Net income from continuing op. 199.00M 1.05B 864.00M 698.00M 382.00M
Minority interests -123.00M -130.00M -41.00M -34.00M -187.00M
Preferred stock dividends

Balance sheet

2023 2022 2021 2020 2019
Fiscal date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets
Current assets
Cash
Cash equivalents
Cash and cash equivalents 2.22B 1.80B 1.57B 2.56B 3.34B
Other short term investments 46.78B 46.58B 60.48B 63.88B 60.58B
Accounts receivable 19.03B 19.00B 16.81B 16.82B 17.10B
Other receivables
Inventory
Prepaid assets
Restricted cash
Assets held for sale
Hedging assets
Other current assets
Non current assets
Properties
Land and improvements
Machinery furniture equipment
Construction in progress
Leases
Accumulated depreciation
Goodwill 198.00M 203.00M 143.00M 157.00M 206.00M
Investment properties
Financial assets
Intangible assets 198.00M 203.00M 143.00M 157.00M 196.00M
Investments and advances 47.18B 46.90B 60.68B 63.88B 60.58B
Other non current assets
Total liabilities
Current liabilities
Accounts payable
Accrued expenses
Short term debt 397.00M
Deferred revenue
Tax payable
Pensions
Other current liabilities
Non current liabilities
Long term debt 1.58B 1.61B 1.90B 3.40B 3.59B
Provision for risks and charges
Deferred liabilities
Derivative product liabilities
Other non current liabilities
Shareholders equity
Common stock 1.00M 1.00M 1.00M 1.00M 1.00M
Retained earnings 1.21B 1.14B 2.49B 1.58B 1.46B
Other shareholders equity -2.56B -2.61B 3.86B 4.43B 3.43B
Total shareholders equity 8.34B 8.39B 16.27B 15.82B 14.63B
Additional paid in capital 11.88B 11.87B 11.86B 12.01B 11.99B
Treasury stock 3.06B 2.76B 2.70B 2.70B 2.70B
Minority interest 855.00M 755.00M 756.00M 502.00M 447.00M

Cash flow statement

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002
Operating Activities
Net Income199.00M1.05B864.00M698.00M382.00M67.00M533.00M-38.00M-6.00M-1.21B680.00M468.00M141.00M195.00M-399.00M-572.00M1.15B1.29B1.19B1.16B1.08B-526.00M
Depreciation
Deferred Taxes48.00M315.00M275.00M228.00M119.00M28.00M-427.00M145.00M-196.00M-341.00M-100.00M82.00M-350.00M-333.00M-476.00M-430.00M252.00M365.00M824.00M-1.20B-63.00M-55.00M
Stock-Based Compensation49.00M37.00M40.00M39.00M26.00M35.00M31.00M32.00M16.00M28.00M39.00M26.00M31.00M44.00M26.00M23.00M41.00M
Other Non-Cash Items-584.00M-692.00M-776.00M-646.00M-699.00M-697.00M-713.00M-782.00M-788.00M-777.00M-812.00M-801.00M-690.00M-506.00M-1.15B-1.60B-1.81B-1.51B-1.30B-7.04B-3.83B-376.00M
Accounts Receivable-377.00M3.15B2.64B3.53B-136.00M
Accounts Payable4.23B406.00M-682.00M2.26B3.60B
Other Assets & Liabilities-79.00M-352.00M14.00M830.00M636.00M598.00M370.00M705.00M293.00M1.52B-361.00M-1.17B-73.00M-298.00M2.29B3.88B6.29B3.98B-637.00M7.28B5.50B4.84B
Operating Cash Flow-367.00M354.00M417.00M1.15B464.00M31.00M-206.00M62.00M-681.00M-778.00M-554.00M-1.39B-941.00M-898.00M296.00M1.30B9.78B7.69B2.04B5.99B6.15B3.89B
Investing Activities
Capital Expenditures
Net Intangibles
Net Acquisitions-384.00M-460.00M-242.00M-267.00M1.40B-5.00M39.00M273.00M365.00M77.00M208.00M-37.00M-51.00M-22.00M-31.00M-511.00M-9.00M1.59B-61.00M
Purchase of Investments-3.23B-4.04B-5.22B-7.76B-6.44B-9.75B-8.48B-11.68B-9.75B-9.22B-10.46B-12.32B-12.41B-13.24B-10.18B-8.41B-15.26B-16.65B-12.97B-16.20B-26.85B-35.41B
Sale of Investments4.66B5.39B6.45B6.71B6.53B9.42B7.96B9.52B9.11B7.58B9.10B11.33B11.52B10.81B9.91B10.58B14.00B14.53B9.66B11.06B24.94B28.88B
Investing Cash Flow991.00M891.00M995.00M-1.32B1.49B-325.00M-525.00M-2.13B-370.00M-1.64B-990.00M-918.00M-689.00M-2.46B-321.00M922.00M-1.86B-2.90B-3.28B-4.94B906.00M-6.53B
Financing Activities
Long-Term Debt Issuance738.00M441.00M150.00M144.00M793.00M361.00M545.00M1.20B2.57B8.20B349.00M598.00M348.00M2.20B600.00M
Long-Term Debt Payments-32.00M-297.00M-1.54B-805.00M-446.00M-640.00M-34.00M-2.04B-217.00M-695.00M-501.00M-1.45B-986.00M-73.00M-9.26B-11.84B-500.00M-550.00M-927.00M-3.04B
Other Financing Charges-1.12B-1.19B-1.41B-1.42B-1.53B-1.31B-1.67B-907.00M-210.00M272.00M-418.00M33.00M-1.14B-2.64B770.00M-3.92B-1.43B-335.00M445.00M753.00M-132.00M2.37B
Financing Cash Flow-1.44B-1.55B-2.42B-1.49B-1.98B-1.51B-1.70B-2.95B-51.00M238.00M-126.00M-1.06B-1.68B-2.33B-5.68B-6.84B-2.31B-835.00M-248.00M854.00M-3.04B-743.00M
Other Cash Details
End Cash Position2.22B1.80B1.57B2.66B3.34B2.18B2.88B2.78B5.97B4.65B3.66B3.63B4.44B3.13B5.00B7.33B3.09B2.44B1.85B1.96B1.98B1.57B
Income Tax Paid
Interest Paid
Free Cash Flow597.00M1.05B437.00M1.96B2.08B1.63B2.55B1.87B1.59B2.44B1.40B962.00M3.13B1.34B1.93B5.44B4.79B4.37B3.48B5.61B3.72B4.88B

Top Institutional Holders

Holder Date Reported Shares Value % Held
iShares Core S&P Smallcap ETF Nov 30, 2024 27,362,221 203.03M 6.41%
Vanguard Total Stock Market Index Fund Sep 30, 2024 13,399,151 99.42M 3.14%
Vanguard Small-Cap Index Fund Sep 30, 2024 10,808,146 80.20M 2.53%
iShares Russell 2000 ETF Nov 30, 2024 10,070,018 74.72M 2.36%
Vanguard Selected Value Fund Oct 31, 2024 9,152,100 67.91M 2.14%
Vanguard Small Cap Value Index Fund Sep 30, 2024 7,321,097 54.32M 1.71%
DFA U.S. Small Cap Value Series Oct 31, 2024 6,843,461 50.78M 1.60%
Vanguard Extended Market Index Fund Sep 30, 2024 6,384,886 47.38M 1.50%
Avantis U.S. Small Cap Value ETF Nov 30, 2024 5,702,579 42.31M 1.34%
iShares S&P Smallcap 600 Value ETF Nov 30, 2024 4,421,394 32.81M 1.04%
Genworth Financial Schedules Earnings Conference Call for February 19 Article
Genworth Financial Schedules Earnings Conference Call for February 19
RICHMOND, Va.--(BUSINESS WIRE)--Genworth Financial, Inc. (NYSE: GNW) today announced it will issue its earnings release containing fourth quarter results after the market closes on February 18, 2025. A conference call will be held on February 19, 2025, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the publ.
Business Wire Neutral
Jan 9, 2025
Stock Picks From Seeking Alpha's October 2024 New Analysts Article
Stock Picks From Seeking Alpha's October 2024 New Analysts
In October, 42 new analysts joined Seeking Alpha, sharing diverse investment ideas and strategies, from biotech to real estate. Highlighted strong buy recommendations include MicroStrategy, CorMedix, Hewlett Packard Enterprise, Vertex Pharmaceuticals, and several others. Readers are encouraged to engage with the new analysts, share thoughts on their picks, and join the conversation.
Seeking Alpha Positive
Nov 8, 2024
Genworth Financial, Inc. (GNW) Q3 2024 Earnings Call Transcript Article
Genworth Financial, Inc. (GNW) Q3 2024 Earnings Call Transcript
Genworth Financial, Inc. (NYSE:GNW ) Q3 2024 Earnings Conference Call November 7, 2024 9:00 AM ET Company Participants Brian Johnson - SVP, Financial Planning and Analysis Thomas McInerney - President and CEO Jerome Upton - CFO Jamala Arland - President and CEO, U.S. Life Insurance Conference Call Participants Brett Osetec - KBW Joshua Esterov - CreditSights Operator Good morning, ladies and gentlemen, and welcome to the Genworth Financial's Third Quarter 2024 Earnings Conference Call. My name is Lisa and I'll be your coordinator today.
Seeking Alpha Neutral
Nov 7, 2024
Scroll to Top

Markets

Crypto

how to invest

Who we are